EVP Business Development and Chief Business Development Officer
Roy Ovel joined TFS as Executive Vice President Business Development in 2014 and leads the global sales and marketing team at TFS.
Roy has nearly 30 years of experience in the pharmaceutical industry with a strong track record of developing and managing high performing global teams and integrating business units across continents.
Roy's career began in the preclinical arena and since those early days his experience has spanned across the drug development continuum. His previous clinical experience includes being the General Manager of Aspect Clinical, VP Business Development with ICON Development Solutions and VP International Business Development with Worldwide Clinical Trials. Prior to joining TFS he was the EVP Global Business Development with KCR. Roy has a degree in Life Sciences and post-graduate diploma in Business Administration. He is a member of the Drug Information Association (DIA).
Roy is located at the TFS office in Uxbridge, UK.